ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $9,462,000 | +66.4% | 136,413 | +4.3% | 0.01% | +40.0% |
Q4 2018 | $5,687,000 | -74.5% | 130,794 | -55.2% | 0.01% | -28.6% |
Q3 2018 | $22,278,000 | +58.2% | 291,820 | +59.3% | 0.01% | -22.2% |
Q2 2018 | $14,082,000 | +41.0% | 183,198 | -6.5% | 0.01% | +28.6% |
Q1 2018 | $9,987,000 | +53.9% | 195,859 | +40.0% | 0.01% | +75.0% |
Q4 2017 | $6,490,000 | +4.7% | 139,938 | +20.3% | 0.00% | 0.0% |
Q3 2017 | $6,197,000 | -16.0% | 116,349 | -2.0% | 0.00% | -20.0% |
Q2 2017 | $7,373,000 | -20.5% | 118,703 | -13.3% | 0.01% | -28.6% |
Q1 2017 | $9,277,000 | -8.2% | 136,873 | -4.8% | 0.01% | -12.5% |
Q4 2016 | $10,106,000 | -5.1% | 143,731 | -4.2% | 0.01% | +14.3% |
Q3 2016 | $10,644,000 | +42.5% | 150,044 | -1.7% | 0.01% | +16.7% |
Q2 2016 | $7,467,000 | -25.4% | 152,665 | -3.5% | 0.01% | -25.0% |
Q1 2016 | $10,011,000 | -43.9% | 158,133 | -0.6% | 0.01% | -38.5% |
Q4 2015 | $17,842,000 | +16.8% | 159,052 | +0.3% | 0.01% | +8.3% |
Q3 2015 | $15,277,000 | +105.9% | 158,620 | +118.9% | 0.01% | +140.0% |
Q2 2015 | $7,420,000 | +251.0% | 72,466 | +112.8% | 0.01% | +400.0% |
Q1 2015 | $2,114,000 | +41.5% | 34,055 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,494,000 | -20.9% | 34,055 | +2.1% | 0.00% | 0.0% |
Q3 2014 | $1,888,000 | +63.6% | 33,356 | +29.8% | 0.00% | 0.0% |
Q2 2014 | $1,154,000 | -2.5% | 25,702 | +6.2% | 0.00% | 0.0% |
Q1 2014 | $1,183,000 | – | 24,197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |